Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical Research

Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation

International Journal of Obesity volume 47, pages 1214–1223 (2023)Cite this article

Subjects

Abstract

Background

Excessive visceral obesity in recipients of living donor liver transplantation (LDLT) is associated with mortality, and a recent study reported the correlation between visceral adiposity of male LDLT recipients and hepatocellular carcinoma (HCC) recurrence. However, there is no study on the relationship between the donor’s visceral adiposity and surgical outcomes in LDLT recipients. We investigated the association of the visceral-to-subcutaneous fat area ratio (VSR) in donors and recipients with HCC recurrence and mortality in LDLT.

Methods

We analyzed 1386 sets of donors and recipients who underwent LDLT between January 2008 and January 2018. The maximal chi-square method was used to determine the optimal cutoff values for VSR for predicting overall HCC recurrence and mortality. Cox regression analyses were performed to evaluate the association of donor VSR and recipient VSR with overall HCC recurrence and mortality in recipients.

Results

The cutoff values of VSR was determined as 0.73 in males and 0.31 in females. High donor VSR was significantly associated with overall HCC recurrence (adjusted hazard ratio [HR]: 1.43, 95% confidence interval [CI]: 1.06–1.93, p = 0.019) and mortality (HR: 1.35, 95% CI: 1.03–1.76, p = 0.030). High recipient VSR was significantly associated with overall HCC recurrence (HR: 1.40, 95% CI: 1.04–1.88, p = 0.027) and mortality (HR: 1.50, 95% CI: 1.14–1.96, p = 0.003).

Conclusions

Both recipient VSR and donor VSR were significant risk factors for HCC recurrence and mortality in LDLT recipients. Preoperative donor VSR and recipient VSR may be strong predictors of the surgical outcomes of LDLT recipients with HCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Kaplan–Meier curves for overall HCC recurrence and mortality.

Similar content being viewed by others

Data availability

The dataset used and/or analyzed during the current study is available from the corresponding author upon reasonable request.

References

  1. Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14:203–17.

    Article  PubMed  Google Scholar 

  2. de’Angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review. World J Gastroenterol. 2015;21:11185–98.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004;10:534–40.

    Article  PubMed  Google Scholar 

  4. Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, et al. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series. Ann Surg Oncol. 2015;22:2286–94.

    Article  CAS  PubMed  Google Scholar 

  5. Koh PS, Chan SC. Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient’s outcome. J Nat Sci Biol Med. 2017;8:4–10.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Brown RS Jr., Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med. 2003;348:818–25.

    Article  PubMed  Google Scholar 

  7. Fahrner R, Dondorf F, Ardelt M, Dittmar Y, Settmacher U, Rauchfuß F. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World J Gastroenterol. 2015;21:12071–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nagai S, Yoshida A, Facciuto M, Moonka D, Abouljoud MS, Schwartz ME, et al. Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology. 2015;61:895–904.

    Article  CAS  PubMed  Google Scholar 

  9. Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220:416–27.

    Article  PubMed  Google Scholar 

  10. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiology. 2012;85:1–10.

    Article  CAS  Google Scholar 

  11. Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48:e12997.

    Article  PubMed  Google Scholar 

  12. Kang HW, Kim D, Kim HJ, Kim CH, Kim YS, Park MJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol. 2010;105:178–87.

    Article  PubMed  Google Scholar 

  13. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM. Visceral obesity and breast cancer risk. Cancer. 1994;74:632–9.

    Article  CAS  PubMed  Google Scholar 

  14. Montano-Loza AJ, Mazurak VC, Ebadi M, Meza-Junco J, Sawyer MB, Baracos VE, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018;67:914–23.

    Article  PubMed  Google Scholar 

  15. Ha Y, Kim D, Han S, Chon YE, Lee YB, Kim MN, et al. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function. Cancer Res Treat. 2018;50:843–51.

    Article  CAS  PubMed  Google Scholar 

  16. Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015;15:17–38.

    Article  PubMed  Google Scholar 

  17. Park HJ, Shin Y, Park J, Kim H, Lee IS, Seo DW, et al. Development and Validation of a Deep Learning System for Segmentation of Abdominal Muscle and Fat on Computed Tomography. Korean J Radiol. 2020;21:88–100.

    Article  PubMed  Google Scholar 

  18. Ouh Y-T, Lee K-M, Ahn KH, Hong S-C, Oh M-J, Kim H-J, et al. Predicting peripartum blood transfusion: focusing on pre-pregnancy characteristics. BMC Pregnancy Childbirth. 2019;19:477.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Park J, Gil JR, Shin Y, Won SE, Huh J, You MW, et al. Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects. PLoS One. 2019;14:e0222042.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.

    Article  PubMed  Google Scholar 

  21. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, et al. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Pham HP, Shaz BH. Update on massive transfusion. Br J Anaesth. 2013;111:i71–82.

    Article  PubMed  Google Scholar 

  23. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma. Liver Cancer. 2019;8:92–109.

    Article  PubMed  Google Scholar 

  24. Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y, et al. Impact of Donor Age on Recipient Survival in Adult-to-Adult Living-donor Liver Transplantation. Ann Surg. 2018;267:1126–33.

    Article  PubMed  Google Scholar 

  25. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant. 2004;4:1302–7.

    Article  PubMed  Google Scholar 

  26. McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol. 2011;54:1055–62.

    Article  PubMed  Google Scholar 

  27. Takagi K, de Wilde RF, Polak WG. The effect of donor body mass index on graft function in liver transplantation: A systematic review. Transplant Rev (Orlando). 2020;34:100571.

    Article  PubMed  Google Scholar 

  28. Berzigotti A, Saran U, Dufour JF. Physical activity and liver diseases. Hepatology. 2016;63:1026–40.

    Article  CAS  PubMed  Google Scholar 

  29. Pantanetti P, Garrapa GG, Mantero F, Boscaro M, Faloia E, Venarucci D. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens. 2004;26:387–98.

    Article  CAS  PubMed  Google Scholar 

  30. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83.

    Article  CAS  PubMed  Google Scholar 

  31. Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4:535–46.

    Article  CAS  PubMed  Google Scholar 

  32. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71:298–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Briceño J, Ciria R. Early graft dysfunction after liver transplantation. Transplant Proc. 2010;42:631–3.

    Article  PubMed  Google Scholar 

  34. Fain JN, Bahouth SW, Madan AK. TNFalpha release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord. 2004;28:616–22.

    Article  CAS  PubMed  Google Scholar 

  35. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443–77.

    Article  CAS  PubMed  Google Scholar 

  36. Rytka JM, Wueest S, Schoenle EJ, Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes. 2011;60:56–63.

    Article  CAS  PubMed  Google Scholar 

  37. Schwenzer NF, Machann J, Schraml C, Springer F, Ludescher B, Stefan N, et al. Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data. Invest Radiol. 2010;45:788–94.

    Article  PubMed  Google Scholar 

  38. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301–13.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR20C0026), and was supported by Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT, Project No. 2021-0-00393). This study was also supported by a grant (2022IP0053) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea).

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Ji-Hoon Sim, Young-Jin Moon, Hye-Mee Kwon, In-Gu Jun, Sung-Hoon Kim, Kyoung-Sun Kim, Jun-Gol Song & Gyu-Sam Hwang

  2. Department of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea

    Kyung-Won Kim & YouSun Ko

Authors
  1. Ji-Hoon Sim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyung-Won Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. YouSun Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young-Jin Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hye-Mee Kwon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. In-Gu Jun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung-Hoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kyoung-Sun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jun-Gol Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gyu-Sam Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JHS and JGS conceived and designed the study; JHS, KYK, YSK, HMK, YJM, IGJ, SHK, and JGS were involved in data acquisition; JHS, HMK, IGJ, and GSH were involved in the analysis and/or interpretation of data; JHS drafted the manuscript; JGS revised the manuscript critically for important intellectual content. All authors gave approval for the final manuscript.

Corresponding author

Correspondence to Jun-Gol Song.

Ethics declarations

Competing interests

The authors declare no competing interests.

Informed consent

The institutional review board of Asan Medical Center (Protocol No. 2021-0526) approved this study. The need for informed consent from individual patients was waived owing to the retrospective nature of the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sim, JH., Kim, KW., Ko, Y. et al. Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation. Int J Obes 47, 1214–1223 (2023). https://doi.org/10.1038/s41366-023-01367-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-023-01367-5

Search

Advanced search

Quick links